News    Sports    Entertainment Log In    My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, March 20, 2010 1:10 AM

Zostavax

Image
Type: Product
Name: Zostavax
First Reported Feb 25 2010 - Updated Feb 25 2010 - 1 Documents

Ancora names Merck vet Buckland to board

Ancora Pharmaceuticals Inc., a Medford-based biopharmaceutical firm, reports it has appointed Barry Buckland to its board of directors.Buckland is currently CEO of BiologicB LLC, a Doylestown, Pa.-based company developing affordable vaccines for developing ... [Published Feb 25 2010 by Mass High Tech]

Quotes

...'Vaccines have been the centerpiece of my scientific career for two decades,' Dr. Shaw said. "I look forward to working with Thomas to continue advancing VaxInnate's vaccines forward to market, where they have the potential to make a lasting contribution to public health." About VaxInnate
Dr. Thomas Hofstaetter Named President and CEO of VaxInnate; Dr. Alan Shaw Assumes New Role as... [Forbes.com - Mar 18 2010]
"Ancora Pharmaceuticals' work with carbohydrates is going to broaden the field of biopharmaceuticals generally," explained Buckland. "This discovery platform will enable a whole new approach to vaccine development and is going to change how the field considers selecting and developing vaccines."
Barry Buckland Joins Ancora Pharmaceuticals Board [FinanzNachrichten.de - Feb 25 2010]

More Content

All (14) | News (13) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (1)
sort by: Date | Relevance
Dr. Thomas Hofstaetter Named President and CEO ... [Forbes.com - Mar 18 2010]
Health Chaos Theory [MedPage Today - Mar 09 2010]
Biologic Product Shortages [U.S. Food and Drug Administration - Mar 02 2010]
Ancora names Merck vet Buckland to board [Mass High Tech - Feb 25 2010]
Barry Buckland Joins Ancora Pharmaceuticals Board [FinanzNachrichten.de - Feb 25 2010]
Merck & Co., Inc. Q4 2009 Earnings Call Tra... [Seeking Alpha - Feb 16 2010]
Highlights From MRK's Q4 Conference Call: Scher... [Street Insider - Feb 16 2010]
Merck announces global sales of $27.4 billion f... [News-Medical.Net - Feb 16 2010]
Merck Announces Fourth-Quarter and Full-Year 20... [FinanzNachrichten.de - Feb 16 2010]
Dr. Peter Honig Brings FDA and Global Regulator... [FinanzNachrichten.de - Feb 16 2010]
Row over age limit for shingles vaccination [Guardian.co.uk - Jan 31 2010]
2010 Forecast: Key Products and Leading Therape... [Pharmaceutical Executive - Dec 09 2009]
Head of Merck vaccines unit will retire [Philadelphia Inquirer - Aug 01 2009]
1
In Focus
  •  
Peter Honig, Barry Buckland, Alan Shaw, [more]
  •  
Merck & Co Inc, Schering Plough Corporation, VaxInnate Corporation, [more]
  •  
Food and Drug Administration, European Union, UK Department of Health, [more]
  •  
Vaccine, Mergers & Acquisitions, Human Health, [more]
  •  
Gardasil, SITAGLIPTIN, Isentress, [more]
  •  
Washington DC, Temecula (United States), New York City, [more]
  •  
United States, Japan, England, [more]
  •  
Medicine, Medication, Biology, [more]
  •  
Pharma & Biotech, IT, Health, [more]
FinanzNachrichten.de, Able2Act, Philadelphia Inquirer, [more]
Content Volume
Document Volume
Network
Network
Products & Services
Silobreaker.com
Enterprise Online Service
Enterprise Software Suite
Widgets & API
How To Use
Silobreaker
RSS
API
Widgets
Advertise With Us
Advertise
Follow Us
Press Room
Blog
YouTube
Twitter
About Us
About Silobreaker
Background and History
Why Silobreaker?
Value Proposition
Technology
Team
Contact Us
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2009 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.